Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Indentification of a Transforming Fragment of Herpes Simplex Type 2 and Detection Thereof in Clinical Specimens

  • Read more about Indentification of a Transforming Fragment of Herpes Simplex Type 2 and Detection Thereof in Clinical Specimens
US Patent 6,617,103
Filed on 1998-12-23

PROTEASE-ACTIVATABLE PSEUDOMONAS EXOTOXIN A-LIKE PROPROTEINS

  • Read more about PROTEASE-ACTIVATABLE PSEUDOMONAS EXOTOXIN A-LIKE PROPROTEINS
US Patent 6,423,513
Filed on 2000-01-10

CHEMOKINE-TUMOR ANTIGEN FUSION PROTEINS AS CANCER VACCINES

  • Read more about CHEMOKINE-TUMOR ANTIGEN FUSION PROTEINS AS CANCER VACCINES
US Application 10/335,394
Filed on 2002-12-31

VECTOR WITH MULTIPLE TARGET RESPONSE ELEMENTS AFFECTING GENE EXPRESSION

  • Read more about VECTOR WITH MULTIPLE TARGET RESPONSE ELEMENTS AFFECTING GENE EXPRESSION
US Application 09/481,209
Filed on 2000-01-11

PSEUDOMONAS EXOTOXIN A-Like CHIMERIC IMMUNOGENS

  • Read more about PSEUDOMONAS EXOTOXIN A-Like CHIMERIC IMMUNOGENS
US Patent 7,314,632
Filed on 2000-04-28

Pseudomonas Exotoxin A-Like Chimeric Immunogens For Eliciting A Secretory IGA-Mediated Immune Response

  • Read more about Pseudomonas Exotoxin A-Like Chimeric Immunogens For Eliciting A Secretory IGA-Mediated Immune Response
US Application 09/462,713
Filed on 2000-05-12

Induction of an Activated Myeloid Dendritic Cell Phenotype

  • Read more about Induction of an Activated Myeloid Dendritic Cell Phenotype
US Application 09/469,589
Filed on 1999-12-22

Agents That Bind to and Inhibit Human Cytochrome P450 2C8, 2C9, 2C18, and 2C19

  • Read more about Agents That Bind to and Inhibit Human Cytochrome P450 2C8, 2C9, 2C18, and 2C19
Patent Cooperation Treaty
PCT/US2000/003673
Filed on 2000-02-11

ENHANCED IMMUNE RESPONSE TO AN ANTIGEN BY A COMPOSITION OF A RECOMBINANT VIRUS EXPRESSING THE ANTIGEN WITH A RECOMBINANT VIRUS EXPRESSING AND IMMUNOSTIMULATORY MOLECULE

  • Read more about ENHANCED IMMUNE RESPONSE TO AN ANTIGEN BY A COMPOSITION OF A RECOMBINANT VIRUS EXPRESSING THE ANTIGEN WITH A RECOMBINANT VIRUS EXPRESSING AND IMMUNOSTIMULATORY MOLECULE
US Patent 6,548,068
Filed on 2000-01-07

Methods and Devices for Isolation and Analysis of Cellular Protein Content

  • Read more about Methods and Devices for Isolation and Analysis of Cellular Protein Content
Patent Cooperation Treaty
PCT/US00/04023
Filed on 2000-02-16

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1509
  • Page 1510
  • Page 1511
  • Page 1512
  • Page 1513
  • Page 1514
  • Page 1515
  • Page 1516
  • Page 1517
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health